$3.70
-0.22-5.61%
Last update: Sep 5, 7:43 PM
15 minutes delayed
Lumos Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lumos Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.93 | $-1.24 | 25.0 % |
Mar 2024 | 2024-05-14 | $-1.29 | $-1.18 | -9.32 % |
Dec 2023 | 2024-03-07 | $-1.17 | $-1.15 | -1.74 % |
Sep 2023 | 2023-11-07 | $-1.04 | $-1.15 | 9.57 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $488.00K | $330.00K | 47.9 % |
Mar 2024 | 2024-05-14 | $165.00K | $300.00K | -45.0 % |
Sep 2023 | 2023-11-07 | $7.00K | $320.00K | -97.8 % |
Jun 2023 | 2023-08-09 | $527.00K | $410.00K | 28.5 % |
Lumos Pharma (LUMO) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.93, which beat the estimate of $-1.24.
The Actual Revenue was $488K, which beat the estimate of $330K.
Browse earnings estimates, EPS, and revenue on all stocks.